CAPITOL HILL CONSULTING GROUP

Lobbying for CLENE NANOMEDICINE · Biopharmaceutical company focused on neurodegenerative diseases,including ALS

Filing 1st Quarter - Amendment

1st Quarter (Jan 1 - Mar 31) 2025 · Utah · House · Senate · $20,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Biopharmaceutical company focused on neurodegenerative diseases, including ALS. Issues related to accelerated approval.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.